Biotechnology
Technology
Health

Acceleron Pharma

387

$96.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.01 (+1.06%) Today
$0.00 (0.00%) As of 6:00 PM EDT after-hours

Why Robinhood?

You can buy or sell XLRN and other stocks, options, ETFs, and crypto commission-free!

About XLRN

Acceleron Pharma Inc. Common Stock, also called Acceleron Pharma, is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Read More Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA.

CEO
Habib J. Dable
Employees
237
Headquarters
Cambridge, Massachusetts
Founded
2003
Market Cap
5.18B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.43M
High Today
$99.73
Low Today
$92.75
Open Price
$93.80
Volume
3.09M
52 Week High
$110.49
52 Week Low
$37.60

Collections

Biotechnology
Technology
Health
Biopharmaceutical
Therapy
Pharmaceutical
2013 IPO
US

XLRN News

ReutersJun 30

BRIEF-Acceleron Announces Pricing Of Public Offering Of Common Stock

June 30 (Reuters) - Acceleron Pharma Inc: * ACCELERON ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK * SAYS PUBLIC OFFERING OF 4.86 MILLION COMMON SHARE
0

XLRN Earnings

-$0.95
-$0.63
-$0.32
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Expected Aug 5, After Hours

You May Also Like

NAD
URTH
MT
GECCN
IMMR
PATK
VNRX
VTR
BBH
EEH
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy XLRN

Market Price$96.28
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell XLRN stock and options commission-free.
LearnBlogCareersHelpLog InSign Up